Page last updated: 2024-08-16

raloxifene and madindoline a

raloxifene has been researched along with madindoline a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jou, D; Kumari, V; Li, C; Li, H; Lin, J; Lin, L; Xiao, H	1

Other Studies

1 other study(ies) available for raloxifene and madindoline a

Article	Year
Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface. Journal of medicinal chemistry, 2014, Feb-13, Volume: 57, Issue:3 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cytokine Receptor gp130; Drug Design; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Indoles; Interleukin-6; Ligands; Molecular Docking Simulation; Phosphorylation; Protein Interaction Domains and Motifs; Protein Multimerization; Raloxifene Hydrochloride; Signal Transduction; STAT3 Transcription Factor	2014

Article

Year

Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface.

Journal of medicinal chemistry, 2014, Feb-13, Volume: 57, Issue:3

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cytokine Receptor gp130; Drug Design; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Indoles; Interleukin-6; Ligands; Molecular Docking Simulation; Phosphorylation; Protein Interaction Domains and Motifs; Protein Multimerization; Raloxifene Hydrochloride; Signal Transduction; STAT3 Transcription Factor

2014